CHLAMYDIA PNEUMONIAE IGM

The CHLAMYDIA PNEUMONIAE IGM test is a serological assay that detects IgM-class antibodies directed against Chlamydia pneumoniae, indicating a recent or acute infection. It is performed on a blood sample (serum) using validated immunoassay techniques to identify early immune response and help distinguish new infection from past exposure.

This test is useful for diagnosing atypical respiratory infections such as persistent cough, low-grade fever, pharyngitis or community-acquired pneumonia where C. pneumoniae is suspected, and it supports timely antimicrobial decision-making. Results should be interpreted in clinical context because IgM can sometimes cross-react or persist; confirmatory testing with PCR or paired IgG serology and clinical correlation may be recommended. Home sample collection and confidential reporting are available across Dubai and the UAE, with clinician guidance provided for follow-up care.

• Chlamydia pneumoniae IgM antibody
• IgM antibody titre / index
• Result interpretation (Positive / Negative / Equivocal)
• Assay method (e.g., ELISA/CLIA)

• Persistent dry cough or worsening respiratory symptoms
• Fever with sore throat, hoarseness, or chest discomfort
• Suspected atypical or community-acquired pneumonia
• Recent close contact with someone with atypical respiratory infection
• Exacerbation of asthma/COPD or symptoms in immunocompromised patients

• Detects recent/acute Chlamydia pneumoniae infection
• Discreet at-home blood collection across Dubai and the UAE
• Confidential lab reporting with prompt clinician guidance
• Supports timely and appropriate antibiotic treatment decisions
• Convenient for high-risk or mobility-limited patients

• Venous blood sample collected by a trained phlebotomist at home
• No fasting required; continue regular medications unless instructed
• Valid Emirates ID and signed consent (parent/guardian consent for minors)
• Inform the collector of recent antibiotic use or immunosuppressive therapy